Skip to content
OpenCapital
Get started

Acumen Pharmaceuticals, Inc. ABOS Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$0.44Beat by $0.19
EPS estimate-$0.63

Next report

Aug 11, 2026 (In 4 weeks)
EPS estimate-$0.39

Versus estimates

Diluted EPS

Q1 2026-$0.33Beat by $0.07Q4 2025-$0.41Beat by $0.09
Q3 2025-$0.44Beat by $0.19
Q2 2025-$0.68Miss by $0.14Q1 2025-$0.48Beat by $0.08Q4 2024-$0.62Miss by $0.15

Ask the moment Acumen Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Acumen Pharmaceuticals, Inc. report Q3 2025 earnings?
Acumen Pharmaceuticals, Inc. (ABOS) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Acumen Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
Acumen Pharmaceuticals, Inc. reported diluted EPS of $-0.44 for Q3 2025.
Did Acumen Pharmaceuticals, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.63 by $0.19.
How did Acumen Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 12.0% from $-0.50.
Where can I find Acumen Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050800) and the 10-Q periodic report (0001576885-25-000104) directly on SEC EDGAR. The filing index links above go to sec.gov.